Brainsway (BWAY) Leases (2025 - 2026)

Brainsway posted quarterly Leases of $5.3 million for Q1 2026, down 3.86% on a QoQ basis from $5.5 million in Q4 2025.

Brainsway (BWAY) has 2 years of Leases data on file, last reported at $5.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Leases changed N/A year-over-year to $5.3 million; the trailing twelve-month figure through Mar 2026 stood at $5.3 million (changed N/A YoY), and the FY2025 full-year result was $5.5 million, changed N/A from the prior year.
  • Leases for Q1 2026 stood at $5.3 million, down from $5.5 million in the prior quarter.
  • Across five years, Leases topped out at $5.5 million in Q4 2025 and bottomed at $5.3 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Leases (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 547.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 99.30 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 73.10 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 396.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 155.20 Mn
10 Brainsway 6.80 Mn -52.98 Mn 11.68 Mn 5.33 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 5.33 Mn
Dec 31, 2025 5.55 Mn